FENC

Fennec Pharmaceuticals Inc

• TipRanks·09/17 13:47

  Fennec’s Pedmark Trial in Japan Shows Strong Hearing Protection Without Hurting Tumor Response

• TipRanks·09/17 11:35

  Fennec presents results from STS-J01 clinical trial evaluating Pedmark

• Dow Jones·09/09 11:28

  Fennec Pharmaceuticals Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

• TipRanks·09/09 10:55

  Analyst Reaffirms Buy on Fennec’s PEDMARK Momentum and Growth Catalysts, Maintains $16 12-Month Target

• TipRanks·08/24 00:14

  Fennec Pharmaceuticals Earnings Call Highlights Strong Momentum

• TipRanks·08/17 09:36

  Fennec price target raised to $18 from $16 at B. Riley

• TipRanks·08/13 15:36

  Fennec Pharmaceuticals (FENC) Gets a Buy from Maxim Group

• Dow Jones·08/12 17:00

  Fennec Pharmaceuticals Price Target Raised to $18.00/Share From $16.00 by B. Riley Securities

• Benzinga·08/12 16:50

  B. Riley Securities Reiterates Buy on Fennec Pharmaceuticals, Raises Price Target to $18

• Dow Jones·08/12 16:14

  Fennec Pharmaceuticals Is Maintained at Outperform by Wedbush

• Dow Jones·08/12 16:14

  Fennec Pharmaceuticals Price Target Raised to $16.00/Share From $13.00 by Wedbush

• Benzinga·08/12 16:04

  Wedbush Maintains Outperform on Fennec Pharmaceuticals, Raises Price Target to $16

• Seeking Alpha·08/12 14:05

  Fennec: The Turnaround Is Real, But The Stock Prices In Perfection (Downgrade)

• TipRanks·08/12 13:55

  Fennec Pharmaceuticals (FENC) Gets a Buy from Wedbush

• TipRanks·08/12 13:40

  Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Immunome (IMNM)